Institutional Ownership Apellis Pharmaceuticals, Inc. (APLS)
This table provides information about the institutional ownership of Apellis Pharmaceuticals, Inc. (APLS). We have compiled data on the 295 institutions that hold shares in the stock, with a total of 132 Million shares, which have been reported (via 13F filing form) to have a value of $3.15 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Avoro Capital Advisors LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
12,222,222
shares
|
$292 Million
3.86% of portfolio
|
Q4 2024
Added 10.0%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
11,895,808
shares
|
$284 Million
17.74% of portfolio
|
Q1 2025
Added 0.04%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
10,154,751
shares
|
$243 Million
0.0% of portfolio
|
Q2 2025
Added 0.24%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
9,752,201
shares
|
$233 Million
0.01% of portfolio
|
Q2 2025
Added 1.31%
|
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
8,976,962
shares
|
$215 Million
0.03% of portfolio
|
Q2 2025
Reduced 27.04%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
7,000,000
shares
|
$167 Million
4.3% of portfolio
|
Q2 2025
Added 40.0%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
5,976,414
shares
|
$143 Million
0.09% of portfolio
|
Q2 2025
Added 46.57%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
5,795,272
shares
|
$139 Million
0.01% of portfolio
|
Q2 2024
Added 5.47%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
4,735,311
shares
|
$113 Million
0.01% of portfolio
|
Q2 2025
Added 44.71%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
3,562,721
shares
|
$85.1 Million
0.0% of portfolio
|
Q2 2025
Reduced 9.61%
|
|
|
Suvretta Capital Management, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
2,878,000
shares
|
$68.8 Million
1.71% of portfolio
|
Q2 2025
Added 74.78%
|
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
2,704,837
shares
|
$64.6 Million
0.06% of portfolio
|
Q2 2025
Added 11373.81%
|
|
|
Jennison Associates LLC
|
Aug 01, 2025 Q2 2025 |
2,661,823
shares
|
$63.6 Million
0.03% of portfolio
|
Q2 2025
Added 7.44%
|
|
|
Siren, L.L.C.
New York, NY |
Aug 13, 2025 Q2 2025 |
2,578,396
shares
|
$61.6 Million
2.31% of portfolio
|
Q1 2025
Reduced 8.45%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
2,426,628
shares
|
$58 Million
0.0% of portfolio
|
Q2 2025
Reduced 22.51%
|
|
|
Norges Bank
Oslo, Q8 |
Aug 13, 2025 Q2 2025 |
2,367,224
shares
|
$56.6 Million
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,995,271
shares
|
$47.7 Million
0.0% of portfolio
|
Q2 2025
Added 2.32%
|
|
|
Amundi
Paris, I0 |
Aug 13, 2025 Q2 2025 |
1,604,105
shares
|
$38.3 Million
0.01% of portfolio
|
Q2 2025
Added 386.71%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Aug 12, 2025 Q2 2025 |
1,496,296
shares
|
$35.8 Million
0.01% of portfolio
|
Q2 2025
Reduced 15.78%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
1,482,300
shares
|
$35.4 Million
0.92% of portfolio
|
Q2 2025
Added 3.49%
|
|
|
Polar Capital Holdings PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
1,352,175
shares
|
$32.3 Million
0.13% of portfolio
|
Q2 2025
Reduced 14.27%
|
|
|
Braidwell LP
Stamford, CT |
Aug 14, 2025 Q2 2025 |
1,121,034
shares
|
$26.8 Million
1.19% of portfolio
|
Q2 2025
Reduced 32.15%
|
|
|
Wells Fargo & Company
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
1,043,655
shares
|
$24.9 Million
0.0% of portfolio
|
Q2 2025
Added 22470.39%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
989,143
shares
|
$23.6 Million
0.0% of portfolio
|
Q2 2025
Added 2.56%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
928,624
shares
|
$22.2 Million
0.1% of portfolio
|
Q2 2023
Added 106.34%
|